Skip to main content
GutCited

Berberine के लिए Gut Dysbiosis

D

Preclinical evidence that berberine modulates microbiome composition. Limited human microbiome data.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dgut\u002Ddysbiosis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

निष्कर्ष

Preclinical evidence that berberine modulates microbiome composition. Limited human microbiome data.

Key Study Findings

In Vitro
Colon-targeted self-assembled nanoparticles loaded with berberine double salt ameliorate ulcerative colitis by improving intestinal mucosal …
Dose: None बनाम: Sulfasalazine; DSS-induced UC mice Outcome: UC treatment efficacy प्रभाव: Colon length 1.2x longer than sulfasalazine None

जनसंख्या: DSS-induced UC murine model

Review
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Review
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Other
Design and Activity Evaluation of Berberine-Loaded Dual pH and Enzyme-Sensitive Colon-Targeting Microparticles.
Dose: None बनाम: Free berberine; DSS-induced UC model vs normal mice Outcome: DAI scores, inflammatory cytokines, gut microbiota प्रभाव: None <0.01 (DAI); <0.05 (cytokines)

जनसंख्या: DSS-induced UC mouse model (male KM mice)

Other
Ulcerative Colitis Aggravates Periodontitis via Inducing Myelopoiesis.
Dose: None बनाम: DSS-induced colitis + periodontitis mouse models Outcome: Periodontal destruction and myeloid cell generation प्रभाव: None None

जनसंख्या: DSS-induced colitis with periodontitis mouse model

Key Statistics

2

अध्ययन

100

प्रतिभागी

Positive

D

ग्रेड

Referenced Papers

Pharmaceuticals (Basel, Switzerland) 2025 8 उद्धरण
Inflammatory bowel diseases 2025 2 उद्धरण
Indian journal of … 2024 2 उद्धरण
Gut microbes 2023 108 उद्धरण
Journal of ethnopharmacology 2023 29 उद्धरण
Current pharmaceutical design 2023 10 उद्धरण
Comprehensive Physiology 2021 21 उद्धरण
Journal of integrative … 2020 33 उद्धरण
Biomedicine & pharmacotherapy … 2019 72 उद्धरण
Alternative therapies in … 2017 9 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
500-1,500 mg/day in divided doses
siboprotocol:
500 mg two to three times daily for 4 weeks (as part of herbal antimicrobial protocol)
giantimicrobial:
500 mg twice daily

अधिकतम सीमा: Generally well-tolerated up to 1,500 mg/day in divided doses

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
None 6 weeks Positive --

सेवन का सर्वोत्तम समय: With meals; divide doses throughout the day (do not take full daily dose at once)

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common
  • May cause uterine contractions (contraindicated in pregnancy)
  • Headache
  • Skin rash (rare)

ज्ञात अंतःक्रियाएँ

  • Diabetes medications (berberine significantly lowers blood sugar; risk of hypoglycemia)
  • Cyclosporine (berberine inhibits CYP3A4, increasing cyclosporine levels)
  • Anticoagulants (may have additive blood-thinning effects)
  • Metformin (additive glucose-lowering effect; monitor closely)
  • Macrolide antibiotics (berberine inhibits CYP3A4)

सहनीय अधिकतम सेवन: Generally well-tolerated up to 1,500 mg/day in divided doses

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Berberine help with Gut Dysbiosis?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Berberine may support Gut Dysbiosis management. Our evidence grade is D (Very Early Research).
How much Berberine should I take for Gut Dysbiosis?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include GI side effects (diarrhea, constipation, flatulence, abdominal pain) — most common, May cause uterine contractions (contraindicated in pregnancy), Headache, Skin rash (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Gut Dysbiosis?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Gut Dysbiosis

Berberine अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।